MEDICXI VENTURES MANAGEMENT (JERSEY) LIMITED
Adviser information for MEDICXI VENTURES MANAGEMENT (JERSEY) LIMITED last updated from Form ADV on March 21st, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Corporation |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Jersey |
Employees
| Total Number of Employees | 0 |
|---|---|
| Investment Advisory/Research | 0 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | No |
|---|
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 0 | $0 |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 0 |
Services
| Advisory Services | – |
|---|---|
| Compensation | – |
Principal Office
44 ESPLANADEST. HELIER
Jersey
Monday - Friday, 9AM TO 5PM
Tel: 441534 713740, Fax: 441534 859077
Chief Compliance Officer
NoneIndustry Affiliates
| MEDICXI GROWTH I GP LIMITED | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MEDICXI III GP LIMITED | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MEDICXI IV GP LIMITED | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MEDICXI SECONDARY I GP LIMITED | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| MEDICXI VENTURES (JERSEY) LIMITED | Other investment adviser, including financial planners |
| MEDICXI VENTURES (UK) LLP | Other investment adviser, including financial planners |
| MEDICXI VENTURES I GP LIMITED | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| MEDICXI GROWTH I LP | Venture Capital Fund | $198.5M | $5.0M | 20 |
| MEDICXI III LP | Venture Capital Fund | $402.9M | $5.0M | 48 |
| MEDICXI IV LP | Venture Capital Fund | $299.5M | $5.0M | 40 |
| MEDICXI SECONDARY I LP | Venture Capital Fund | $271.8M | $5.0M | 30 |
| MEDICXI VENTURES I LP | Venture Capital Fund | $310.6M | $5.0M | 20 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| Johnstone-Scott, Giles | Individual | – | DIRECTOR | 11/2015 | < 5% |
| DE RUBERTIS, FRANCESCO | Individual | – | SHAREHOLDER | 12/2015 | 50-75% |
| Lee, Richard | Individual | – | DIRECTOR | 12/2015 | 10-25% |
| WIGNALL, ANDREW | Individual | – | DIRECTOR | 12/2015 | < 5% |
| CHESNAY, FRANCOIS, XAVIER ALAIN HENRI | Individual | – | DIRECTOR | 03/2017 | < 5% |
| Lee, Richard | Individual | – | SHAREHOLDER | 02/2021 | 10-25% |
| Mariggi, Giovanni | Individual | – | SHAREHOLDER | 02/2021 | 10-25% |
| LIEW, GAILINA, JIA-HSIN | Individual | – | DIRECTOR | 02/2023 | < 5% |
| CROCKER, NIGEL | Individual | – | DIRECTOR | 07/2022 | < 5% |
No. Employees, Historic
Holdings
From latest 13F, filed July 16th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| AURA BIOSCIENCES INC | COM | 23M | 3M | Francesco De Rubertis |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 180M | 20M | Francesco De Rubertis |
| PHATHOM PHARMACEUTICALS INC | COM | 77M | 7M | Francesco De Rubertis |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 55M | 3M | Francesco De Rubertis |